Literature DB >> 33173460

Role of Plasma Exchange in a Steroid- and IVIG-Refractory Patient with Acute Disseminated Encephalomyelitis: A Case Report.

Parmatma Prasad Tripathi1, Rekha Hans1, Ratti Ram Sharma1, Divjot Singh Lamba1, Preeti Paul1, Naveen Sankhyan2, Chandana Bhagwat2, Paramjeet Singh3.   

Abstract

BACKGROUND: Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease usually affecting children and is treated with high-dose steroid therapy. CASE REPORT: An 8-year boy presented with limbs weakness and complete loss of vision and was resistant to steroid therapy. He was further treated with plasma exchange and showed full recovery from the neurological deficit.
CONCLUSION: Therapeutic plasma exchange appears to be effective in ADEM patients in reversing the neuropathological process especially refractory to steroids and intravenous immunoglobulin.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Acute disseminated encephalomyelitis; Intravenous immunoglobulin; Plasma exchange; Steroid therapy

Year:  2020        PMID: 33173460      PMCID: PMC7588735          DOI: 10.1159/000504987

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  24 in total

1.  Plasmapheresis in fulminant acute disseminated encephalomyelitis.

Authors:  R Miyazawa; A Hikima; Y Takano; H Arakawa; T Tomomasa; A Morikawa
Journal:  Brain Dev       Date:  2001-10       Impact factor: 1.961

Review 2.  Acute disseminated encephalomyelitis.

Authors:  J M K Murthy
Journal:  Neurol India       Date:  2002-09       Impact factor: 2.117

3.  Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Authors:  Zbigniew M Szczepiorkowski; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Beth H Shaz; Robert Weinstein; Ashka Wirk; Jeffrey L Winters
Journal:  J Clin Apher       Date:  2007-06       Impact factor: 2.821

4.  Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children.

Authors:  J L Hynson; A J Kornberg; L T Coleman; L Shield; A S Harvey; M J Kean
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

Review 5.  Acute disseminated encephalomyelitis: an update.

Authors:  Til Menge; Bernhard Hemmer; Stefan Nessler; Heinz Wiendl; Oliver Neuhaus; Hans-Peter Hartung; Bernd C Kieseier; Olaf Stüve
Journal:  Arch Neurol       Date:  2005-11

6.  Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis.

Authors:  Nathan P Young; Brian G Weinshenker; Joseph E Parisi; B Scheithauer; C Giannini; Shanu F Roemer; Kristine M Thomsen; Jayawant N Mandrekar; Bradley J Erickson; Claudia F Lucchinetti
Journal:  Brain       Date:  2010-02-03       Impact factor: 13.501

Review 7.  Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.

Authors:  Daniela Pohl; Gulay Alper; Keith Van Haren; Andrew J Kornberg; Claudia F Lucchinetti; Silvia Tenembaum; Anita L Belman
Journal:  Neurology       Date:  2016-08-30       Impact factor: 9.910

8.  Therapeutic plasma exchange in acute disseminated encephalomyelitis in children.

Authors:  Cristina Borras-Novell; Enric García Rey; Luis Francisco Perez Baena; Iolanda Jordan Garcia; Dolors Catella Cahiz; Francisco Cambra
Journal:  J Clin Apher       Date:  2015-08-31       Impact factor: 2.821

9.  Acute Disseminated Encephalomyelitis.

Authors:  Alexandros Tselis
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.972

10.  Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: a retrospective study.

Authors:  Chang-Hui Xiong; Yan Yan; Zhen Liao; Shi-Hui Peng; Hai-Rong Wen; Yan-Xia Zhang; Shu-Hua Chen; Jian Li; Hai-Ying Chen; Xiao-Wu Feng; Hui-Qing Yao; Li Huang; Li Zhang
Journal:  BMC Public Health       Date:  2014-02-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.